am 580 has been researched along with re 80 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashino, H; Morita, I; Murota, S; Oikawa, T; Okayasu, I; Shudo, K | 1 |
| Hashimoto, Y; Heersche, JN; Von Schroeder, HP | 1 |
| Blomhoff, HK; Engedal, N; Ertesvag, A | 1 |
3 other study(ies) available for am 580 and re 80
| Article | Year |
|---|---|
Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo.
Topics: Animals; Benzoates; Cell Differentiation; Chick Embryo; Dose-Response Relationship, Drug; Neovascularization, Pathologic; Tetrahydronaphthalenes | 1993 |
The effects of natural and synthetic retinoids on the differentiation of RCJ C5.18 chondrogenic cells.
Topics: Animals; Benzoates; Cartilage; Cell Differentiation; Cell Line; Chalcone; Chalcones; Dose-Response Relationship, Drug; Glycosaminoglycans; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Retinoids; Teratogens; Tetrahydronaphthalenes; Transcription Factors; Tretinoin | 1994 |
Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; Benzoates; Cell Survival; Cells, Cultured; DNA Fragmentation; Flow Cytometry; Humans; Interleukin-2; Lectins, C-Type; Lymphocyte Activation; Propidium; Receptors, Retinoic Acid; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tetrahydronaphthalenes; Tretinoin | 2004 |